Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ck, Donat"'
Autor:
Rötering S, Deuther-Conrad W, Cumming P, Ck, Donat, Scheunemann M, Fischer S, Xiong G, Steinbach J, Peter, Sabri O, Bucerius J, Brust P
Publikováno v:
EJNMMI Research, 4:43. SpringerOpen
Europe PubMed Central
Europe PubMed Central
Background: The alpha 7 nicotinic acetylcholine receptor (nAChR) is an important molecular target in neuropsychiatry and oncology. Development of applicable highly specific radiotracers has been challenging due to comparably low protein expression. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b90cbe81d7362765d4eb7207cd5231c9
https://cris.maastrichtuniversity.nl/en/publications/57346277-a6aa-4519-8d75-7c6f029d4106
https://cris.maastrichtuniversity.nl/en/publications/57346277-a6aa-4519-8d75-7c6f029d4106
Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands.
Autor:
Krutzek F; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstrasse 400, 01328, Dresden, Germany., Donat CK; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstrasse 400, 01328, Dresden, Germany., Stadlbauer S; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstrasse 400, 01328, Dresden, Germany. s.stadlbauer@hzdr.de.; School of Science, Faculty of Chemistry and Food Chemistry, Technical University Dresden, 01069, Dresden, Germany. s.stadlbauer@hzdr.de.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 Feb 19; Vol. 9 (1), pp. 14. Date of Electronic Publication: 2024 Feb 19.
Autor:
Krutzek F; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Donat CK; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Ullrich M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Stadlbauer S; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstraße 4, 01069 Dresden, Germany.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2023 Dec 14; Vol. 66 (23), pp. 15894-15915. Date of Electronic Publication: 2023 Dec 01.
Autor:
Craig A; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany., Kogler J; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, D-01062 Dresden, Germany., Laube M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany., Ullrich M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany., Donat CK; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany., Wodtke R; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany., Kopka K; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, D-01062 Dresden, Germany., Stadlbauer S; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, D-01062 Dresden, Germany.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2023 Dec 10; Vol. 15 (12). Date of Electronic Publication: 2023 Dec 10.
Autor:
Krutzek F; Helmholtz Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Department of Medicinal Radiochemistry, Bautzner Landstraße 400, 01328 Dresden, Germany., Donat CK; Helmholtz Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Department of Medicinal Radiochemistry, Bautzner Landstraße 400, 01328 Dresden, Germany., Stadlbauer S; Helmholtz Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Department of Medicinal Radiochemistry, Bautzner Landstraße 400, 01328 Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technical University Dresden, 01069 Dresden, Germany.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 11; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 11.
Autor:
Krutzek F; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Donat CK; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Ullrich M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Zarschler K; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Ludik MC; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Feldmann A; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Loureiro LR; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Kopka K; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Mommsenstraße 4, 01069 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Fetscherstraße 74, 01307 Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307 Dresden, Germany., Stadlbauer S; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Mommsenstraße 4, 01069 Dresden, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2023 May 06; Vol. 15 (9). Date of Electronic Publication: 2023 May 06.
Autor:
Naseer S; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK., Abelleira-Hervas L; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK., Savani D; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK., de Burgh R; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK., Aleksynas R; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK., Donat CK; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK., Syed N; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK., Sastre M; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
Publikováno v:
Biomolecules [Biomolecules] 2022 Oct 11; Vol. 12 (10). Date of Electronic Publication: 2022 Oct 11.
Autor:
Haase-Kohn C; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany., Laube M; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany., Donat CK; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Translational TME-Ligands, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany., Belter B; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany., Pietzsch J; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01069 Dresden, Germany.
Publikováno v:
Cells [Cells] 2022 Feb 21; Vol. 11 (4). Date of Electronic Publication: 2022 Feb 21.
Autor:
Calsolaro V; Department of Brain Sciences, Imperial College London, London, UK., Matthews PM; Department of Brain Sciences, Imperial College London, London, UK.; UK Dementia Research Institute, Imperial College London, London, UK., Donat CK; Department of Brain Sciences, Imperial College London, London, UK.; Centre for Blast Injury Studies, Imperial College London, London, UK., Livingston NR; Department of Brain Sciences, Imperial College London, London, UK., Femminella GD; Department of Brain Sciences, Imperial College London, London, UK., Guedes SS; Department of Brain Sciences, Imperial College London, London, UK., Myers J; Department of Brain Sciences, Imperial College London, London, UK., Fan Z; Department of Brain Sciences, Imperial College London, London, UK., Tyacke RJ; Department of Brain Sciences, Imperial College London, London, UK., Venkataraman AV; Department of Brain Sciences, Imperial College London, London, UK., Perneczky R; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.; German Centre for Neurodegenerative Disorders (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial College London, London, UK., Gunn R; Department of Brain Sciences, Imperial College London, London, UK.; Invicro, London, UK., Rabiner EA; Invicro, London, UK.; King's College London, London, UK., Gentleman S; Department of Brain Sciences, Imperial College London, London, UK., Parker CA; Department of Brain Sciences, Imperial College London, London, UK.; GlaxoSmithKline, Stevenage, UK., Murphy PS; GlaxoSmithKline, Stevenage, UK., Wren PB; GlaxoSmithKline, Stevenage, UK., Hinz R; Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK., Sastre M; Department of Brain Sciences, Imperial College London, London, UK., Nutt DJ; Department of Brain Sciences, Imperial College London, London, UK., Edison P; Department of Brain Sciences, Imperial College London, London, UK. paul.edison@imperial.ac.uk.; Cardiff University, Cardiff, Wales, United Kingdom. paul.edison@imperial.ac.uk.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2021 Oct; Vol. 26 (10), pp. 5848-5855. Date of Electronic Publication: 2021 Jul 15.
Autor:
Graham NSN; Department of Brain Sciences, Imperial College London, London W12 0NN, UK.; UK DRI Centre for Care Research and Technology, Imperial College London, London W12 0BZ, UK., Zimmerman KA; Department of Brain Sciences, Imperial College London, London W12 0NN, UK.; UK DRI Centre for Care Research and Technology, Imperial College London, London W12 0BZ, UK., Moro F; Laboratory of Acute Brain Injury and Therapeutic Strategies, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo 24126, Italy.; Fondazione IRCCS, Ca' Granda Ospedale Maggiore Policlinico, Dipartimento di Anestesia e Rianimazione, 20122, Milan, Italy., Heslegrave A; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London WC1N 3BG, UK., Maillard SA; Neuroscience Critical Care Research Group, Department of Intensive Care Medicine, CHUV Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland., Bernini A; Neuroscience Critical Care Research Group, Department of Intensive Care Medicine, CHUV Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland., Miroz JP; Neuroscience Critical Care Research Group, Department of Intensive Care Medicine, CHUV Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland., Donat CK; Department of Brain Sciences, Imperial College London, London W12 0NN, UK., Lopez MY; Centre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, UK., Bourke N; Department of Brain Sciences, Imperial College London, London W12 0NN, UK.; UK DRI Centre for Care Research and Technology, Imperial College London, London W12 0BZ, UK., Jolly AE; Department of Brain Sciences, Imperial College London, London W12 0NN, UK.; UK DRI Centre for Care Research and Technology, Imperial College London, London W12 0BZ, UK., Mallas EJ; Department of Brain Sciences, Imperial College London, London W12 0NN, UK.; UK DRI Centre for Care Research and Technology, Imperial College London, London W12 0BZ, UK., Soreq E; Department of Brain Sciences, Imperial College London, London W12 0NN, UK.; UK DRI Centre for Care Research and Technology, Imperial College London, London W12 0BZ, UK., Wilson MH; Department of Neurosurgery, Imperial College Healthcare NHS Trust, London W6 8RF, UK.; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK., Fatania G; Department of Imaging, Imperial College Healthcare NHS Trust, London W6 8RF, UK., Roi D; Department of Imaging, Imperial College Healthcare NHS Trust, London W6 8RF, UK., Patel MC; Department of Imaging, Imperial College Healthcare NHS Trust, London W6 8RF, UK., Garbero E; Laboratory of Clinical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo 24126, Italy., Nattino G; Laboratory of Clinical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo 24126, Italy., Baciu C; Neurorianimazione, ASST Grande Ospedale Metropolitano Niguarda, Milano 20162, Italy., Fainardi E; Department of Experimental and Clinical Sciences, Careggi University Hospital, University of Firenze, Florence 50139, Italy., Chieregato A; Neurorianimazione, ASST Grande Ospedale Metropolitano Niguarda, Milano 20162, Italy., Gradisek P; Clinical Department of Anaesthesiology and Intensive Therapy, University Medical Center, Ljubljana 1000, Slovenia., Magnoni S; Department of Anesthesia and Intensive Care, Santa Chiara Hospital, Trento 38122, Italy., Oddo M; Neuroscience Critical Care Research Group, Department of Intensive Care Medicine, CHUV Lausanne University Hospital and University of Lausanne, Lausanne 1011, Switzerland.; Medical Direction, CHUV Lausanne University Hospital, Lausanne 1011, Switzerland., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal 431 41, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal 431 41, Sweden., Bertolini G; Laboratory of Clinical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo 24126, Italy., Sharp DJ; Department of Brain Sciences, Imperial College London, London W12 0NN, UK.; UK DRI Centre for Care Research and Technology, Imperial College London, London W12 0BZ, UK.; Centre for Injury Studies, Imperial College London, London SW7 2AZ, UK.
Publikováno v:
Science translational medicine [Sci Transl Med] 2021 Sep 29; Vol. 13 (613), pp. eabg9922. Date of Electronic Publication: 2021 Sep 29.